Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Methampehtamine use and risk of HIV in men

New findings that one in 20 North Carolina men who have sex with men (MSM) reported using crystal methamphetamine during the previous month suggests increased risk for spreading HIV and other sexually transmitted diseases (STD), according to researchers from Wake Forest University School of Medicine and colleagues.

28 Aug 2007

Sildenafil increases release of key reproductive hormone oxytocin

Researchers at the University of Wisconsin-Madison report this month that sildenafil increases the amount of oxytocin released by stimulation of the posterior pituitary gland, a small structure directly underneath the brain that regulates hormone levels in response to neural signals.

24 Aug 2007

People ages 57 to 85 think of sexuality as an important part of life

The first comprehensive national survey of sexual attitudes, behaviors and problems among older adults in the United States has found that most people ages 57 to 85 think of sexuality as an important part of life and that the frequency of sexual activity, for those who are active, declines only slightly from the 50s to the early 70s.

24 Aug 2007

Group talk helps men with erectile dysfunction

Taking part in group psychotherapy can help men who have erectile dysfunction to over come their problem, and adding sildenafil to group therapy was more effective that sildenafil alone.

18 Jul 2007

Tackling counterfeit Chinese pharmaceuticals

Agencies worldwide are cracking down on counterfeit pharmaceuticals, and much of the focus has been on China, where an official was recently executed for approving fake medicines.

17 Jul 2007

Australian study finds no magic pill will solve all erectile problems

Medications are not quite a magic pill to improve the sex lives of men with erectile problems, a Deakin University study has found.

11 Jul 2007

FDA cracks down on dietary supplements

It's taken a few years but the Food and Drug Administration (FDA) in the U.S. has finally established a set of regulations to ensure good manufacturing practices for dietary supplements.

25 Jun 2007

Solvay Pharmaceuticals submits supplemental NDA for AndroGel

Solvay Pharmaceuticals, Inc., has announced that it submitted a supplemental New Drug Application (sNDA) for AndroGel (testosterone gel) 1% CIII to the U.S. Food and Drug Administration (FDA) for treatment in male adolescents ages 13-17 years old with primary or secondary hypogonadism.

17 Jun 2007

Treatment for early prostate cancer associated with type of specialist seen

A new study analyzing men with localized prostate cancer shows that the specialty of the physician they see can influence the type of therapy they ultimately receive.

5 Jun 2007

Gene therapy delivery of nerve growth factors reverses erectile dysfunction in mice

Rats with erectile dysfunction, or ED, that were injected with a gene therapy vector containing either of two nerve growth factors were able to regain normal function after four weeks, according to a study conducted by University of Pittsburgh School of Medicine researchers.

5 Jun 2007

Botox for enlarged prostate

Injecting botulinum toxin A, or Botox, into the prostate gland of men with enlarged prostate, eased symptoms and improved quality of life up to a year after the procedure, according to a study by researchers at the Chang Gung University Medical College, Taiwan, and the University of Pittsburgh School of Medicine.

24 May 2007

FDA issues consumer warning for "True Man" or "Energy Max" products

The Food and Drug Administration (FDA) is advising consumers not to purchase or use "True Man" or "Energy Max" products promoted and sold as dietary supplements throughout the United States.

11 May 2007

Regular exercise associated with reduced risk of benign prostatic hyperplasia

Protection against heart disease, stroke, diabetes, obesity, hypertension, memory loss, colon cancer, fractures, and depression should be enough to get men exercising.

4 May 2007

Top 10 diseases by cost

Bladder, prostate and other urinary tract diseases cost Americans nearly $11 billion a year, according to a new report from the National Institutes of Health.

2 May 2007

Prostate cancer treatments impact on quality of life

A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways.

24 Apr 2007

Long-term study of prostate cancer treatments

A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways.

24 Apr 2007

Low serum testosterone levels independently associated with fall risk in elderly men

Prolonged hypogonadism may result in erectile dysfunction, decreased libido, anemia, sarcopenia, memory loss, bone mineral loss, and the metabolic syndrome.

15 Apr 2007

Erectile dysfunction drugs may be better than nitroglycerin in protecting the heart after a severe heart attack

During a heart attack, the heart is deprived of oxygen, which can result in significant damage to heart muscle and tissue. After the attack, most patients require treatment to reduce and repair the damage and improve their chances of survival.

5 Mar 2007

FDA approves antidepressant Cymbalta (duloxetine HCl) for treatment of generalized anxiety disorder

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.

26 Feb 2007

Early detection of erectile dysfunction helps diagnosis of heart disease

During the month of February, Heart Health Month, the Erectile Dysfunction Institute (EDi) is encouraging all men currently experiencing erectile dysfunction (ED) to visit their cardiologist to be examined for cardiovascular disease.

31 Jan 2007